Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-11-20

Clinical Trial Update: Autologous Bone Marrow Stem Cell Transplantation for Osteonecrosis in Sickle Cell Disease [Phase 1, Phase 2]

View source ↗

Summary

This entry provides an update on a Phase 1/Phase 2 clinical trial evaluating autologous bone marrow stem cell transplantation for osteonecrosis in patients with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Autologous bone marrow stem cell transplantation

Snippet

Sponsor: Federal University of Bahia | Conditions: Avascular Necrosis of Bone, Sickle Cell Disease | Phase 1, Phase 2 | Status: UNKNOWN